EUVIMEDEUVIMED entdecken
Open Access

FSP1 and histone deacetylases suppress cancer persister cell ferroptosis

Masayoshi Higuchi iD, August F Williams iD, Anna E Stuhlfire iD, Ariel H Nguyen iD, David A G Gervasio iD, Claire E Turkal, Suejean Chon, Matthew J Hangauer iD

Science Advances · 02.01.2026 · 12 (1)

DOI: 10.1126/sciadv.aea8771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 02.01.2026. Verfasst von Masayoshi Higuchi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, University of California San Diego, San Diego, CA, USA. Hauptthemen laut MEDLINE: Ferroptosis, Histone Deacetylases, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer persister cells which survive oncogene targeted therapies are sensitized to ferroptosis, but mechanistic understanding of this vulnerability remains limited. Here, we found that while levels of iron, glutathione, and various ferroptosis-suppressing enzymes vary among persister cell types, ferroptosis suppressor protein 1 (FSP1) is down-regulated in multiple persister cell types, and persister cells which survive glutathione peroxidase 4 (GPX4) inhibition rely on residual FSP1 to survive. Furthermore, persister cells which survive GPX4 inhibition down-regulate oxidative phosphorylation, a key source of mitochondrial reactive oxygen species which are required for persister cell ferroptosis. We also found that persister cell treatment with histone deacetylase inhibitors induces reactive oxygen species and sensitizes multiple persister cell types to GPX4 inhibition. Together, these findings reveal that FSP1 and histone deacetylases suppress persister cell ferroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisHistone DeacetylasesNeoplasmsHumansReactive Oxygen SpeciesHistone Deacetylase InhibitorsCell Line, TumorPhospholipid Hydroperoxide Glutathione PeroxidaseGlutathione

Substanzen

Reactive Oxygen SpeciesHistone DeacetylasesHistone Deacetylase InhibitorsPhospholipid Hydroperoxide Glutathione PeroxidaseGlutathione

Autor:innen und Institutionen

  • Department of Dermatology, School of Medicine, University of California San Diego, San Diego, CA, USA.
  • Moores Cancer Center, University of California San Diego, San Diego, CA, USA.
  • Altman Clinical and Translational Research Institute, University of California San Diego, San Diego, CA, USA.

ORCID-Profile: Masayoshi Higuchi, August F Williams, Anna E Stuhlfire, Ariel H Nguyen, David A G Gervasio, Matthew J Hangauer

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • U.S. Department of Defense
  • American Cancer Society
  • V Foundation for Cancer Research

Zitieren

APA

Higuchi, M., Williams, A. F., Stuhlfire, A. E., Nguyen, A. H., Gervasio, D. A. G., Turkal, C. E., Chon, S., & Hangauer, M. J. (2026). FSP1 and histone deacetylases suppress cancer persister cell ferroptosis. Science Advances, 12(1). https://doi.org/10.1126/sciadv.aea8771

Vancouver

Higuchi M, Williams AF, Stuhlfire AE, Nguyen AH, Gervasio DAG, Turkal CE, et al. FSP1 and histone deacetylases suppress cancer persister cell ferroptosis. Science Advances. 2026;12(1). doi:10.1126/sciadv.aea8771

BibTeX
@article{Higuchi2026,
  author = {Higuchi, Masayoshi and Williams, August F and Stuhlfire, Anna E and Nguyen, Ariel H and Gervasio, David A G and Turkal, Claire E and Chon, Suejean and Hangauer, Matthew J},
  title = {FSP1 and histone deacetylases suppress cancer persister cell ferroptosis},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {1},
  doi = {10.1126/sciadv.aea8771}
}
Kostenlos starten →